2026 - - - - - - - - - - - - - - - - - -​

​

January

Research from Dr. Orbach's postdoc, Dynamic Immune Cell Composition, Phenotypes, and Signaling in an Engineered Metastatic Niche, has been published in Biotechnology and Bioengineering.

​

2025 - - - - - - - - - - - - - - - - - -​

​

October

The Orbach Lab had its first outing at BMES. Hoi Yan Yu gave an oral presentation and both Morgan Antisell and Ella Pennington gave poster presentations. Great job team!

​​

Morgan Antisell and Hoi Yan Yu were each awarded Virtua Health College Doctoral Fellowship Awards! Congrats Morgan and Yan! More info can be found here.

​

May

Morgan Antisell passed his preliminary exam!

​

Connor Thomas graduated with his B.S. in Biomedical Engineering! Congrats, Connor!

​

April

Hoi Yan Yu passed her preliminary exam!​

​

Research from Dr. Orbach's postdoc, Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles, has been published in Molecular Oncology.

​​

February

Research from Dr. Orbach's postdoc, Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis, has been published in PNAS.

​

January

Nick Sanchez joined the lab as an undergraduate student!

​

2024 - - - - - - - - - - - - - - - - - -

​

September

Ella Pennington joined the lab as an undergraduate student!

​​

July

Research from Dr. Orbach's postdoc, Dynamic Transcriptional Programs During Single NK Cell Killing: Connecting Form to Function in Cellular Immunotherapy, has been published in Cellular and Molecular Bioengineering.

​

May

Nick Carney graduated with his B.S. in Biomedical Engineering! He will be starting his master's at Rutgers this Fall. Congrats, Nick!

​

2023 - - - - - - - - - - - - - - - - - -

​​​

October

Morgan Antisell and Hoi Yan Yu joined the Orbach Lab as its first Ph.D. students!

​

September

Nick Carney and Connor Thomas joined the Orbach Lab as its first undergraduate students!

​

Research from Dr. Orbach's postdoc, An engineered niche delineates metastatic potential of breast cancer, has been published in Bioengineering and Translational Medicine.